We describe a computationally designed enzyme, formolase (FLS), which catalyzes the carboligation of three one-carbon formaldehyde molecules into one three-carbon dihydroxyacetone molecule. The existence of FLS enables the design of a new carbon fixation pathway, the formolase pathway, consisting of a small number of thermodynamically favorable chemical transformations that convert formate into a three-carbon sugar in central metabolism. The formolase pathway is predicted to use carbon more efficiently and with less backward flux than any naturally occurring one-carbon assimilation pathway. When supplemented with enzymes carrying out the other steps in the pathway, FLS converts formate into dihydroxyacetone phosphate and other central metabolites in vitro. These results demonstrate how modern protein engineering and design tools can facilitate the construction of a completely new biosynthetic pathway.
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computational protein design | pathway engineering | carbon fixation N ovel strategies are needed to address current challenges in energy storage and carbon sequestration. One approach is to engineer biological systems to convert one-carbon compounds into multicarbon molecules such as fuels and other high value chemicals. Many synthetic pathways to produce value-added chemicals from common feedstocks, such as glucose, have been constructed in organisms that lack one-carbon anabolic pathways, such as Escherichia coli or Saccharomyces cerevisiae (1-3); however, despite considerable effort, it has been difficult to introduce heterologous one-carbon fixing pathways into these organisms (4) . Likely problems include the inherent complexity, environmental sensitivity, inefficiency, or unfavorable chemical driving force of naturally occurring one-carbon metabolic pathways (5) .
An optimal pathway for one-carbon utilization in common synthetic biology platforms would be (i) composed of a minimal number of enzymes, (ii) linear and disconnected from other metabolic pathways, (iii) thermodynamically favorable with a significant driving force at most or all steps, and (iv) capable of functioning in a robust manner under both aerobic and anaerobic conditions (5) . A pathway with these properties could enable the assimilation of one-carbon molecules as the sole carbon source for the production of fuels and chemicals. Although no such pathway is known in nature, the established electrochemical reduction of carbon dioxide to formate under ambient temperatures and pressures in neutral aqueous solutions provides an attractive starting point for a onecarbon fixation pathway (5) (6) (7) (8) .
We describe the computational design of an enzyme that catalyzes the carboligation of three one-carbon molecules into a single three-carbon molecule. This enzyme enables the construction of a new pathway, the formolase pathway, in which formate is converted into the central metabolite dihydroxyacetone phosphate (DHAP; Fig. 1 ). The use of computational protein design to reengineer catalytic activities opens up the pathway design space beyond that available based on existing enzymes.
Results
Identification of a Starting Point for a Carboligation Catalyst. The direct coupling of formate into a multicarbon molecule has no precedent in the biochemical literature, but the coupling of formaldehyde (FALD) into dihydroxyacetone (DHA; the formose reaction) has been well characterized in organic synthesis (9) . No enzyme, however, has been previously reported to catalyze this reaction (9) . Therefore, initial efforts focused on designing such an enzyme. In considering how to catalyze this reaction, we were guided by the observation that thiazolium salts catalyze the formose reaction. As thiazolium is the core functional moiety of thiamine pyrophosphate (TPP)-dependent enzymes, we explored this class of enzymes for those potentially capable of performing Significance This paper describes the development of a computationally designed enzyme that is the cornerstone of a novel metabolic pathway. This enzyme, formolase, performs a carboligation reaction, directly fixing one-carbon units into three-carbon units that feed into central metabolism. By combining formolase with several naturally occurring enzymes, we created a new carbon fixation pathway, the formolase pathway, which assimilates one-carbon units via formate. Unlike native carbon fixation pathways, this pathway is linear, not oxygen sensitive, and consists of a small number of thermodynamically favorable steps. We demonstrate in vitro pathway function as a proof of principle of how protein design in a pathway context can lead to new efficient metabolic pathways.
the formose reaction. We identified the enzyme benzaldehyde lyase (BAL) as a promising starting point (Figs. 1A and 2A). Although BAL has not previously been demonstrated to catalyze the formose reaction, it catalyzes the related coupling of two benzaldehyde (BzALD) molecules into benzoin. The primary difference between these reactions is that the conversion of FALD to DHA requires two rounds of carbon-carbon coupling steps, whereas BzALD to benzoin requires only one. We hypothesized that, although multiple carbon-carbon couplings with BzALD are not feasible due to the single aldehyde hydrogen on BzALD, FALD has two aldehyde hydrogens and could potentially undergo two rounds of carbon-carbon coupling (SI Appendix, Fig. S1 ). To investigate possible formose activity, the gene for BAL from Pseudomonas fluorescens biovar I was synthesized, and the corresponding enzyme was expressed and purified as described in Materials and Methods (10) .
BAL formose activity was assessed using two independent assays. First, incubation of BAL with 13 C-FALD led to new peaks in the NMR spectra. The chemical shifts and J-coupling correspond to the expected two carbon [glycolaldehyde (GALD), first carbon-carbon coupling of two FALDs] and the three-carbon (DHA) 13 C products of the formose reaction (SI Appendix, Fig.  S2 ). Second, the catalytic efficiency of BAL for the formose reaction was determined using a coupled enzyme assay in which DHA or GALD is reduced by the NADH-dependent enzyme glycerol dehydrogenase. Enhanced NADH oxidation rates were detected only in the presence of all of the components, and activity was dependent on both the concentration of FALD and BAL. The k cat /K M of BAL for the formose reaction was estimated from linear fits to substrate vs. velocity profiles (no saturation was observed at up to 20 mM FALD) and found to be ∼5.0 × 10 Fig. S1 ), 36,000-fold lower than the
; Table 1 ). The elucidation of the mechanism and full product profile of the formose reaction will require further quantitative analysis.
Computational Design of a Formose Catalyst. Next, computational protein design was used to redesign the BzALD binding pocket of BAL to increase specificity and activity for FALD and the formose reaction. FALD molecules-much smaller than the native ligand BzALD ( Fig. 2A and SI Appendix, Fig. S3 )-were modeled into the BAL crystal structure, and RosettaDesign and Foldit calculations were used to fill in the considerable empty space to increase binding affinity for FALD (Fig. 2B and SI Appendix, Fig. S3 ). Four iterations of computational design and experimental evaluation ranging from 1 to 42 designs per cycle, with 121 designs in total evaluated, led to a variant we call Des1 with 26-fold higher activity and four amino acid substitutions: A28I, A394G, G419N, and A480W ( Fig. 2B and SI Appendix, Fig. S3 ). In this design, a new hydrogen bond is predicted to form between the DHA transition state and G419N. In addition, packing interactions are predicted to occur with A480W and A28I on the carbon backbone of DHA.
To determine if these mutations had a significant effect on the structure, we crystalized and solved the structure of Des1 (SI Appendix, Fig. S4 and Table S2 ). The RMSD between Des1 and BAL was 0.6 Å, and there were no significant changes in backbone structure throughout the active site ( Fig. 2C and SI Appendix, Fig. S3 ). Comparison of the three mutated nonglycine amino acids showed that the computational modeling was accurate, as all three displayed the same rotameric conformation as in the original design.
One additional mutation was then identified through a round of computationally guided site-directed mutagenesis (L90T; SI Appendix, Fig. S4 ), and two mutations were found through errorprone PCR (W89R and R188H; SI Appendix, Fig. S4 ) that together further increased activity of Des1 fourfold. The mutation L90T, which reduces the size of the corresponding side chain at that position is near one of the original four computationally engineered mutations, G419N, and may be important for fine-tuning binding interactions. The two mutations from error-prone PCR are at the protein-protein interface, and their role is unclear. We crystalized and solved the structure of this seven-site mutant [A28I, W89R, L90T, R188H, A394G, G419N, and A480W, termed formolase (FLS); SI Appendix, Fig. S4 and Table S2 ]. The identity and position of the additional mutated side chains was clear in the electron density, and the overall conformation of the protein backbone and active site was similar to the Des1 construct (RMSD of ∼0.4 Å across all main chain atoms). FLS has a catalytic efficiency for the formose reaction of 4.7 M
, which is roughly a 100-fold increase in formose activity from the original BAL enzyme (Table 1) . Furthermore, FLS exhibited no detectable activity for the benzoin reaction at concentrations up to 10 μM enzyme and 20 mM BzALD over 1 h. Based on the detection limit of the assay, this is a >100,000-fold decrease in benzoin activity, resulting in a specificity switch between BAL and FLS of greater than 10 million-fold.
Reduction of Formate into FALD. An active FLS creates the opportunity to design a pathway to convert formate to DHAP (Fig. 1) . The first conversion, the direct reduction of formate to FALD, has a very low redox potential (E o′ ∼ −600 mV at pH 7 and ionic strength of 0.2 M, considerably lower than any cellular electron carrier). Hence, the direct reduction of formate using NADH is an extremely unfavorable reaction. To enable the overall desired conversion of formate to FALD, we sought to activate formate to formyl-CoA, reducing the thermodynamic barrier for the reduction to FALD by NADH (Fig. 1D) . No enzymes are known to carry out this reaction, but acetyl-CoA synthase (ACS) carries out a similar reaction with a related compound, acetate (Fig. 1B) , and the differences between formate and acetate should not significantly affect the reaction chemistry. Formyl-CoA is not produced or hydrolyzed in any known primary metabolic pathway of E. coli (11) . In addition, under standard E. coli cytoplasmic conditions, the ATP-dependent formation of formyl-CoA can have a Δ r G′°as low as −4 kcal/mol (12, 13) . Because E. coli has an ACS enzyme, we cloned the gene from the genomic DNA, and the corresponding enzyme (ecACS) was expressed and purified as described in Materials and Methods (14, 15) . EcACS-dependent 13 C-labeled formyl-CoA production was assayed using a previously established liquid chromatographytandem mass spectrometry (LC-MS/MS) method and adjusting the expected masses to correspond to formyl-CoA as described in Materials and Methods. A clear signal for the expected parent and product ion of 13 C-labeled formyl-CoA was observed in the presence of 13 C-formate, ATP, and ecACS (SI Appendix, Fig. S5 ), but not in the absence of any substrate.
The second step of the pathway is the reduction of formylCoA to FALD. There is no enzyme established to catalyze this reaction, but there are enzymes known to catalyze the reversible reduction of acetyl-CoA into acetaldehyde. We tested acylating acetaldehyde dehydrogenase (ACDH; Fig. 1C ) for its ability to produce formyl-CoA from FALD, CoA, and NAD. Little activity was observed with the E. coli ACDH enzyme (SI Appendix, Table S1 ), so we used the BRENDA database to identify a set of five homologous ACDH enzymes (SI Appendix, Table S1 ) (16) (17) (18) . Genes encoding the native sequence for each enzyme were synthesized, and the proteins produced and purified as described in Materials and Methods. The proteins were assayed for NADH production using HSCoA and either acetaldehyde or FALD as substrates (SI Appendix, Table S1 ). The most active of the enzymes, a putative acylating aldehyde dehydrogenase from Listeria monocytogenes, lmACDH, had a catalytic efficiency with FALD of 5.3 M −1 ·s −1 , ∼100-fold greater for FALD and 400-fold greater for acetaldehyde than ecACDH.
We next characterized the conversion of formate to FALD by ecACS and lmACDH acting in tandem (Fig. 1D, stage 2) . The oxidation of NADH was monitored in the presence of formate, CoA, ATP, NADH, ecACS, and lmACDH. Significant NADH oxidation was observed only in the presence of both enzymes (SI Appendix, Fig. S5 ). Thus, consistent with the independent assays on each individual enzyme, the two enzymes together are capable of reducing formate to FALD. The ACS activity appears to be limiting as there was a significant reduction in rate on decreasing ecACS 10-fold, whereas a 10-fold reduction of the lmACDH concentration had little effect.
The Formolase Pathway. On establishing the individual steps for the conversion of formate into DHA, we constructed the entire pathway, which derives both the carbon and the NADH from formate. The formolase pathway has four key stages ( Fig. 1D ): (i) generation of reducing equivalents by FDH, (ii) carbon activation and reduction by ecACS and lmACDH, (iii) carbon-carbon bond formation by FLS, and (iv) assimilation into a central metabolite by phosphorylation of DHA using DHA kinase (DHAK). To explore the ability for this pathway to function in vitro, we incubated 13 C-formate with purified FDH, ecACS, lmACDH, FLS, and DHAK at room temperature and followed the appearance of 13 C-labeled DHAP using LC-MS/MS. In the presence of all of the enzymes, substrates, and cofactors, 13 C-DHAP was clearly observed and increased linearly over time (Fig. 3A) . In the absence of 13 C-formate, FDH, ecACS, lmACDH, or FLS, no 13 C-DHAP was formed (Fig. 3B) . The replacement of FLS with an equivalent protein concentration of BAL eliminates detectable production of 13 C-DHAP. Thus, the functionality of the entire pathway is dependent on the computationally designed molecular interactions in the FLS enzyme.
To probe for bottlenecks in the pathway, we independently titrated the concentration of ecACS, lmACDH, and FLS and measured 13 C-DHAP production rates (Fig. 3B) . Decreasing FLS or ecACS by 10-fold resulted in 6-fold and 4-fold decreases in the rate of DHAP production, respectively, indicating that both ecACS and FLS are partially rate limiting. A 10-fold decrease in lmACDH concentration did not decrease product formation, consistent with the previous identification of ecACS as the rate limiting of the two enzymes. Overall, these results are consistent with our designed pathway and identify FLS and ecACS as bottlenecks to target for future enzyme engineering efforts.
After ascertaining pathway activity with purified enzymes, we expressed the pathway in a single strain to determine feasibility in a cellular context. We tested clarified cellular lysates from ALA2.1, a fdoG MG1655-derived E. coli strain, expressing DHAK from S. cerevisiae (yDHAK), ecACS, lmACDH, and FLS for conversion of 13 C-formate into cellular intermediates. The lysate was incubated with appropriate cofactors and commercial FDH, and incorporation of 13 C-formate into pathway and central metabolic intermediates was measured via LC-MS/MS. Clear increases in the 13 C-labeled metabolite DHAP and downstream glycolytic intermediates, 2/3-phosphoglycerate (2/3-PG; Fig. 4 ), were detected only in the presence of labeled formate with the pathway present. Controls lacking ecACS, lmACDH, and FLS did not yield increased 13 C-labeled DHAP in the presence of 13 C-formate regardless of formate presence. More than 40% labeling of the DHAP and 2/3-PG pools was achieved after 24 h (SI Appendix, Fig. S6 ). The ALA2.1 strain containing the genes for ecACS, 
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The catalytic efficiency (k cat /K M in units of M −1 ·s −1 ) for both FLS and BAL for both the benzoin and formose reaction obtained from linear fits to substrate vs. velocity profiles, as described in Materials and Methods. All fits had at least four independently measured rates with an R 2 > 0.9 and are shown in SI Appendix, Fig. S1 . n.d.a., no detectable activity.
lmACDH, FLS, yDHAK, formate dehydrogenase from Candida methylitica (cmFDH), and formate transporters (FocA or FocB) (19, 20) was tested for formate-dependent growth on agar plates and in liquid cultures, but none was detected.
Discussion
The unique enzyme functions identified and designed here provide a potential route for the biocatalytic conversion of onecarbon molecules into central metabolites. The formolase pathway compares favorably in many respects with the nine known naturally occurring pathways for one-carbon utilization starting from formate or carbon dioxide ( Fig. 5) (6, 21) . It requires only five steps to convert the carbon source into a central metabolite, fewer than all naturally occurring pathways. It is also predicted to support a biomass yield higher than any other pathway [6.5 g cellular dry weight (gCDW)/mol formate] except the reductive tricarboxylic acid (rTCA) cycle (6.7 gCDW/mol formate) (6) . However, the rTCA cycle is thermodynamically unfavorable in the cytosolic conditions of E. coli and uses oxygen-sensitive enzymes, whereas the formolase pathway is thermodynamically favorable and can function under full aerobic conditions (6, 21) . In addition to highly efficient carbon utilization, the formolase pathway has a high chemical driving force (>3 kcal/mol) throughout its entire reaction sequence, a driving force considerably higher than in any other pathway ( This report provides a demonstration of FLS activity and a proof-of-principle demonstration for the potential of a formolase pathway. At this point, the activities of the enzymes involved in the pathway are low, likely contributing to the lack of detectable growth on formate. In addition, the pathway involves on the highly reactive FALD. There are clear routes forward to address both issues. First, it should be possible to significantly increase enzyme activities by a combination of design and selection considering that no optimization was carried out with either ecACS or lmACDH. Second, it should be possible to repurpose microbial microcompartments such as the carboxysome, which have evolved to harbor pathways with reactive one-to-twocarbon components, now that the targeting signals for directing enzymes to these compartments are becoming better understood (22) (23) (24) . Once in vivo metabolic activity of the pathway is established, the formolase pathway could be further extended to use CO 2 as a sole carbon and energy source through the electrochemical reduction of CO 2 into formate (25).
Almost all synthetic biology efforts to date have recombined naturally occurring components. For the full promise of this exciting field to be realized, it will be necessary to broaden the palette of components to include new designed proteins specifically built for the problem at hand-naturally occurring proteins are optimized for the challenges faced during biological evolution and not the current challenges we face today. The coupling of computational design-exemplified by the 100-fold increase in FLS activity and the 10 million-fold switch in specificity-with metabolic engineering described here represents a powerful approach to addressing 21st century challenges.
Materials and Methods
For additional information, please see SI Appendix, SI Materials and Methods.
Cloning. Codon-optimized versions of the genes for BAL, FLS, lmACDH, cmFDH, and yDHAK were obtained from Genescript cloned into pET29b+ vectors (Novagen). ecACDH and ecACS were amplified from genomic material and cloned into the pET29b+ expression vector between NcoI and BamHI. pTrcCO 2 -3 was designed for simultaneous expression of the three critical enzymes in the formolase pathway. EcACS, Des1, and lmACDH were placed under control of a single isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible trc promoter in the expression vector pTrcHis2C (Invitrogen) by Gibson cloning. An alternate system of expressing ecACS, ecACDH, yDHAK, and Des1 was also constructed (SI Appendix, SI Materials and Methods).
yDHAK and cmFDH were combined in constructs along with formate transporter, focA, or putative formate transporter, focB. Genes for yDHAK and cmFDH were amplified from pET29b+ yDHAK and pET29b+ cmFDH. focA and focB were amplified from E. coli BL21 genomic DNA. These PCR products were cloned via the Biobrick system into vector backbone pSB3K3 with a high constitutive expression cassette (BBa_K314100) or a low constitutive expression cassette (BBa_K314101) in various combinations (26-28). (-)FLS C-2/3-PG (2/3-PG M+3) in clarified cell lysates with the pathway genes for ecACS, lmACDH, FLS, and yDHAK (pTrcCO 2 -3, pSB3K3 yDHAK), or in the absence of the key formate assimilation enzymes with only yDHAK (pTrcHis2, pSB3K3 yDHAK), after incubation with 13 C-formate for 24 h. Commercial FDH was added to balance the net NADH oxidation rate of the test extracts in a 1:1 ratio as described in Materials and Methods. Error bars represent the SE of measurements for three biological replicates.
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Enzyme Engineering.
Computational design. The reaction intermediate for DHA was built into the crystal structure of BAL (2AG0) based on the geometric orientation observed for the related reaction intermediate observed in 3FSJ (a closely related enzyme, benzylformate decarboxylase, with a mechanism based covalent inhibitor bound to TPP) using ChemDraw 3D (29, 30). The 3D coordinates are provided in SI Appendix, Table S3 . This model was used as input for RosettaDesign and Foldit-based optimization using previously described methods (31, 32). Briefly, Rosetta was used to evaluate the overall energy of the system as well as the interface energy between the protein and intermediate. Either Monte Carlo combinatorial optimization of amino acid identity and conformation was carried out using RosettaDesign, or substitutions were manually introduced using Foldit. During design, neighboring side chains were allowed to change conformations and the overall protein backbone and the protein-ligand rigid body interface were subjected to gradient based minimization. Selected sequences were experimentally characterized as described in the text. At each round, the model with the lowest overall system energy was selected for analysis of the interactions with the reaction intermediate, and as starting points for the RosettaDesign and Foldit calculations (SI Appendix, SI Materials and Methods, Design Cycle Summary Des1). Mutants were constructed using Kunkel mutagenesis (33), and corresponding proteins were produced, purified, and assayed as described below.
Error-prone PCR library. The Agilent Genemorph II Kit was used according to the manufacturer's protocol to introduce on average two mutations per kilobase into the Des1 gene. After amplification, the mutant library was restriction cloned into pET29b+ using NdeI and XhoI sites and electroporated into E. coli DH5α. Mutation frequency was verified by sequencing 24 isolated clones. A total of 528 colonies were screened using the protein production, purification, and assays in a 96-well microtiter plate format. The top seven mutations were combined combinatorially using Kunkel mutagenesis (33); from which a second set of 528 random colonies was screened. In this screened set, mutants with up to three simultaneous mutations were observed. The enzyme with the highest activity was further optimized through computationally guided site-directed mutagenesis.
Computationally guided Kunkel library construction. Using the Rosetta Molecular Modeling Suite, every point mutation within 15 Å of the Des1 enzyme active site was systematically mutated into each of the twenty amino acids. After generating the ∼2,000 point mutants, all residues within 20 Å of the active site were repacked and minimized in the context of the modeled FLS transition state. Mutants with Rosetta energy greater than that of the unmutated protein were discarded (∼50% of all mutants). The remaining substitutions were sorted by energy, and a total of 380 (up to five at any position) were selected for construction and experimental characterization. Each point mutation was generated using standard Kunkel mutagenesis techniques as previously reported (33). Structure determination. Structures of Des1 and FLS were solved with X-ray crystallography. The methods and the final data and refinement statistics are reported in SI Appendix, SI Materials and Methods and Table S2 , respectively. X-ray crystallographic coordinate data have been deposited in the Protein Data Bank under ID codes 4QPZ (Des1) and 4QQ8 (FLS).
Protein Purification. Constructs, pET29b+ versions, were transformed into chemical competent E. coli strain BL21 (DE3). A single colony was picked and cultured overnight in 3 mL terrific broth (TB) medium at 37°C. This culture was decanted into 0.5 L of TB medium and incubated at 37°C until midlog phase. Expression of the gene of interest was induced with 1 mM IPTG. After 30 h, the cells were pelleted by centrifugation, resuspended in PBS, pH 7.5, 1 mM β-mercaptoethanol (βME), 1 mM MgSO 4 , 0.2 mM TPP, and 10 mM imidazole and lysed by sonication in the presence of lysozyme. Lysates were cleared of cell debris by centrifugation and purified using Talon resin in a gravity-fed column (Clontech). The resin was washed three times with 20 mL PBS, pH 7.5, 1 mM βME, 1 mM MgSO 4 , 0.2 mM TPP, and 10 mM imidazole. Elution was done with 15 mL PBS, pH 7.5, 1 mM βME, 1 mM MgSO 4 , 0.2 mM TPP, and 200 mM imidazole. Eluate was concentrated to ∼1 mL before dialysis against PBS, pH 7.5, 0.5 mM βME, 1 mM MgSO 4 , and 0.2 mM TPP.
Enzyme Assays. Unless otherwise noted, chemicals were sourced from Sigma. Kinetic constant determination. Kinetic constants for BAL and FLS were measured over a 1-h period in 100 mM KPO 4 buffer, pH 8.0, 1 mM MgSO 4 , and 0.1 mM TPP. Enzyme concentrations ranged from 1 to 40 μM, and substrate (either FALD or BzALD) concentrations ranged from 20 to 1.3 mM. FALD to DHA was measured using the coupled enzyme assay described later. Benzoin formation was measured by quenching the reaction in acetonitrile every 10 min and measuring benzoin through liquid chromatography. Kinetic constants for each enzyme using either FALD or benzoin as a substrate were calculated using nonlinear regression fitting of rate of product production as a function of substrate concentration using the (5) RuMP (4) Xy5P (3) FLS (3) Fig. 5 . Thermodynamics and carbon utilization efficiencies. Biomass yield, in gram cellular dry weight (gCDW) per mole of formate consumed, was calculated using flux balance analysis and the core metabolic model of E. coli supplemented with pathway enzymes and without considering ATP maintenance (6) . The MDF is the lowest value of −Δ r G′ in the pathway [for the reaction(s) with the smallest chemical driving force force] (37). Squares correspond to pathways that can directly assimilate formate, whereas circles mark carbon fixation pathways that can indirectly assimilate formate following oxidation. Numbers in parentheses indicate the number of foreign enzymes that need to be expressed in E. coli to establish an active pathway. Pathway abbreviations are as follows: DCHB, dicarboxylate-4-hydroxypropionate cycle; FLS, formolase pathway; HPBC, 3-hydroxypropionate bicycle; HPHB, 3-hydroxypropionate-4-hydroxybutyrate cycle; rAC, reductive acetyl-CoA pathway; rPP, reductive pentose phosphate cycle/Calvin-Benson-Bassham cycle; rTCA, reductive TCA cycle; RuMP, ribulose 4-phosphate cycle; SER, serine cycle; Xy5P, xylulose 5-phosphate cycle/dihydroxyacetone cycle).
TALON beads. Three rounds of washing were followed by elution at high imidazole. Protein content of the flow through was measured using A280, and the coupled FLS enzyme assay was used to detect FLS activity. Lysate-based robotic high-throughput screening. The computationally directed FLS Kunkel library was assessed with robotic high-throughput screening. Inoculated with single colonies, 1,860 overnight cultures, an approximate fivefold oversampling of the library size, were used to start TB expression cultures in deep well plates. At midlog phase, 0.5 mM IPTG was added to induce expression overnight at 18°C. Cell pellets were harvested by centrifugation and stored at −80°C until screening. Cells were lysed chemically and centrifuged to remove debris. A plate format coupled FLS assay was performed on the supernatants. Unique variants were then purified further for detailed kinetic analysis, as described above. In vitro crude cell lysate assay. Chemically competent E. coli, ALA2.1, described in SI Appendix, SI Materials and Methods was transformed with appropriate constructs. Cell pellets were created as in the robotic high-throughput screening, except expression occurs for 24 h. Thawed pellets were resuspended in 3 mL protein buffer (10 mM KPO 4 , pH 8.0, 1 mM MgSO 4 , 0.1 mM TPP, and 0.025 mM DTT). Cell lysates were prepared by two passages through a french press (SIM-Aminco; Spectronic Instruments) with minicell (1,000 psig), followed by ultracentrifugation (Beckman) at 4°C and 45,000 rpm (Beckman MLS 50 rotor) for 1 h and desalting with PD-10 columns (GE Healthcare).
NADH oxidation rates of the resulting clarified cell lysates (CCLs) were measured using a variant of the coupled ACS-ACDH activity assay with 150 mM KPO 4 , 0.2 mM TPP, 2 mM MgSO 4 , 11 mM ATP, 0.5 mM NADH, 0.2 mM HSCoA, 50 mM 13 C-sodium formate, and 0.1 mM DTT. NAD reduction rates by FDH from Candida boidinii (10 mg/mL) were measured in the same assay mixture with NAD replacing NADH and without HSCoA. The FDH solution to CCL volumetric ratio was determined by balancing the average NADH oxidation rate of the full pathway CCLs to that of the FDH in a 1:1 ratio. This ratio was applied to all CCLs to give CCL + FDH 1:1 mixtures.
The assay mixture [as above with 1 mM NAD instead of NADH and 50% (vol/vol) CCL + FDH 1:1 preparations] was vortexed and then incubated at room temperature. Every 8 h, additional ATP, 13 C-formate, and DTT were added to boost concentrations by 2.5 mM, 10 mM, and 10 μM, respectively. At each time point, 150 μL of the reaction was flash frozen in liquid nitrogen and stored at −80°C. 13 C Formaldehyde in the absence of BAL. B) 12 C Glycolaldehyde scanned for natural abundance 13C, in the absence of BAL. C) 12 C Dihydroxyacetone scanned for natural abundance 13 C, in the absence of BAL. D) BAL in the absence of 13 C formaldehyde. E) Reaction mix with BAL (100 µM) and 13 C Formladehyde (10 mM) with 0.1 mM TPP and 2 mM MgSO4 in pH 8.0 phosphate buffer. F) Zoom into the low field region 214-216 ppm. The reaction (purple) shows the expected J-coupling for middle carbon of 1,2,3-13 Cdihydroxyacetone (triplet, 1:2:1) around the natural abundance 13 C dihdyroxyacetone standard (green). G) Zoom into the low field region 66-70 ppm. The reaction (purple) shows the expected J-coupling for end carbons of 1,2,3-13 C -dihydroxyacetone (doublet, 1:1) around the natural abundance 13 C dihdyroxyacetone standard (green). Small peaks are also observed split around the natural abundance 13 C glycolaldehyde standard (red). 13 C labeled formyl-CoA via LC-MS/MS was measured to confirm its production from 13 C formate by ecACS with HSCoA and ATP present. All components were required for significant 13 C formyl-CoA production. B) NADH oxidation by an ACS/ACDH coupled assay with formate and acetate as substrates. NADH consumption was largest with acetate as a substrate. Achieving over 40% of the NADH consumption with formate as a substrate required 10 times as much of each enzyme.
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13
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SI Materials and Methods
Cloning
Codon-optimized versions of BAL, FLS, lmACDH, cmFDH and yDHAK were obtained from Genescript cloned into pET29b+ vectors (Novagen). ecACDH and ecACS were amplified from genomic material and cloned into the pET29b+ expression vector between NcoI and BamHI.
pTrcCO2-3 was designed for simultaneous expression of the three critical enzymes in the formolase pathway. All three genes (ecACS, Des1 and lmACDH) are under control of a single IPTG inducible trc promoter. A Shine-Delgarno sequence precedes each open reading frame. ACS was further amplified from this pET29b+ based template using the following primers:
Trc-ACS CGATTAAATAAGGAGGAATAAACCATGGGAAGCCAGATCCACAAGCATACCAT
RBS2-R CATATGACTTTCCTTTATTAGTGGTGGTGGTGGTGGTGCT
FLS was amplified from pET29b+ FLS using the following primers: RBS2-FLS-F CACCACTAATAAAGGAAAGTCATATGGCTATGATTACTGGTGGTGAACTG G RBS3-R CATTTGACTTTCCTTTACTAGTGGTGGTGGTGGTGGTGCT lmACDH was amplified from pET29b+ lmACDHusing the following primers:
The expression vector pTrcHis2C (Invitrogen), was subjected to restriction digest by NcoI, BamHI and CIP, then gel purified. All PCR products were gel purified (Qiagen). All three gene fragments were assembled into the linearized vector in one step via the method described by Gibson et al. (1) . Ten ng of backbone DNA was used per reaction, along with equi-molar amounts of each insert. NEB 5-alpha cells were transformed with 1 µL of the Gibson product by the heat-shock method. Transformants were selected on LB/Agar carbenicillin plates and sequenced for the correct assemblage of inserts.
An alternate system of expressing ecACS, ecACDH, yDHAK and Des1 was also constructed. Two biscistronic operons were synthesized by DNA2.0 and subcloned by digestion with EcoRI and PstI (NEB) and ligation with T4 DNA ligase (Promega) into Biobrick vectors to give pSB1A3 Des1-yDHAK (constitutive promoter) and pSB3K3 ecACS_ecACDH (lac inducible promoter)(2). yDHAK and cmFDH were combined in additional constructs along with formate transporter, focA and putative formate transporter, focB. Genes for yDHAK and cmFDH were amplified from pET29b+ yDHAK and pET29b+ cmFDH. yDHAK XbaI Fwd-new GCTGGTCTAGAAAAAATGAGCGCTAA yDHAK BBSuffix Rev-new GAAAGTATAGGAACTTCACTTCATTTTCTGC cmFDH29b_XbaIadd_Fwd GCTGGTCTAGATGAAAATCGTCCTGGTTCTGTATG cmFDH29b_BBSuffixadd_ Rev AGTTGACTGCAGCGGCCGCTACTAGTATCATTAGGAACCGCCCTTTTT ATCGT focA and focB were amplified from E. coli BL21 genomic DNA. F_FocA gtttcttcgaattcgcggccgcttctagaggtgaaagctgacaacccttttgatcttttac R_FocA gtttcttcctgcagcggccgctactagtattaatggtggtcgttttcacgcagg F_FocB gtttcttcgaattcgcggccgcttctagatgagaaacaaactctctttcgacttgc R_FocB gtttcttcctgcagcggccgctactagtatcagggttcctgacgtaaataaatagcc These PCR products had the necessary cut sites to function in the Biobrick system and were cloned using that associated method into vector backbone pSB3K3 with high constitutive expression cassette (BBa_K314100) or low constitutive expression cassette (BBa_K314101) in various combinations(2-4). pSB3K3 J23100 DHAK and a set of four constructs, pSB4C5 J23100/114 cmFDH J23114 yDHAK J23114 FocA/B (pSB4C5 FDF3-6), were created.
Strain Manipulations
E. coli K-12 MG1655 with pSB1A3 FLS-DHAK and pSB3K3 ACS-ACDH, were serial passaged daily with a minimal medium containing formate and glycerol. Over 85 passages, formate levels were increased from 0 mM to 60 mM and glycerol levels were decreased from 40 mM to 5 mM. Cultures were grown at 37 ˚C with 225 rpm shaking. Resulting strain was cured of plasmids by plating on antibiotic-free LB agar until replica plating with both kanamycin (Kan) and ampicillin confirmed sensitivity. The resulting strain was named ALA2.
A Keio collection knockout strain for fdoG, which encodes FDH-O, CGSC 10790, was obtained from the Coli Genome Stock Center(5). The Kan-marked mutation was transferred to ALA2 via P1 phage transduction to give ALA2.1 (6) . The Kan marker cassette was removed as described by Datsenko and Wanner(7).
Enzyme Engineering
Computational Design
The transition state for dihydroxyacetone was built into the crystal structure of benzaldehyde lyase (2AG0) based on the geometric orientation observed for the related reaction intermediate observed in the 3FSJ PDB using ChemDraw 3D (8, 9) . This model was used as input for RosettaDesign and Foldit-based optimization using previously described methods (10, 11) . Briefly, Rosetta was used to evaluate the overall energy of the system as well as the interface energy between the protein and intermediate. Either Monte Carlo combinatorial optimization of amino acid identity and conformation was carried out using RosettaDesign, or substitutions were manually introduced using FoldIt. During design, neighboring side chains were allowed to change conformations and the overall protein backbone and the protein-ligand rigid body interface were subjected to gradient based minimization. Selected sequences were experimentally characterized as described in the text. At each round, the model with the lowest overall system energy was selected for analysis of the interactions with the reaction intermediate, and as starting points for the RosettaDesign and FoldIt calculations.
Design Cycle Summary Des1
All designs were conducted using the Foldit interface to the Rosetta Molecular Modeling Suite. The input ligand of the DHA intermediate and TPP cofactor, positioned within the active site based on the crystal structure cofactor as described in Materials and Methods, was fixed in space during modeling. All designs were produced and purified as described in the Materials and Methods. The specific activity of all mutants were determined by comparing specific activity at 20 mM formaldehyde under the conditions described in Kinetic Constant determination in Materials and Methods. 
Mutations
Error-prone PCR library The Agilent Genemorph II Kit was used according the manufacturer's protocol to introduce on average two mutations per kilobase into the Des1 gene. After amplification, the mutant library was gel purified, digested for 1 hour at 37˚C with NdeI and XhoI (NEB), desalted using a Qiagen PCR purification kit, ligated into a NdeI and XhoI digested pET29b+ vector, and electroporated into E. coli DH5α. Mutation frequency was verified by sequencing 24 isolated clones.
Computationally directed Kunkel library construction
Using the Rosetta Molecular Modeling Suite, every point mutation within 15 Å of the Des1 enzyme active site was systematically mutated into each of the twenty amino acids, which equated to roughly 2000 unique mutants. Two thousand instances of EnzdesFixBB.linuxiccrelease (version 40019M) each systematically specifying a single position to be mutated to one of the 20 amino acids were run using Des1 as the protein structure input with the following flags:
-run:version -correct -corrections::score:no_his_his_pairE #Add ch_bond_bb_bb 0.5 to weights file in database -corrections::score:hbond_His_Phil_fix # Add fa_cust_pair_dist 1.0 to weights file in database -run::preserve_header -extra_res_fa LG.params #The Rosetta parameterized ligand, coordinates provided in S12 -enzdes::detect_design_interface -enzdes::cut1 0.0 -enzdes::cut2 0.0 -enzdes::cut3 20.0 -enzdes::cut4 30.0 -enzdes::cst_design -enzdes::cst_min -enzdes::bb_min -enzdes::bb_min_allowed_dev 0.05 -enzdes::chi_min -enzdes::design_min_cycles 1 -enzdes::cstfile S28I.enzdes.cst #distance csts from crystal structure between TPP and protein to ensure it maintains original position -mute core.io.database -score:weights enzdes.wts -packing::use_input_sc -packing::flip_HNQ -linmem_ig 10 -docking::ligand::old_estat #Add hack_elec 0.25 to weights file -enzdes::lig_packer_weight 1.8 -nstruct 10 -nblist_autoupdate After generating the point mutations, all residues within 20 Å of the active site were repacked and minimized in the context of the modeled formolase transition state. Mutants with Rosetta energy calculated to be greater than the un-mutated protein were discarded (~50% of all mutants). The remaining mutants were then sorted by energy and a total of 380 mutants (up to five at each position) were selected for experimental characterization. Each point mutation in the following list was generated using standard Kunkel mutagenesis techniques as previously reported (12) .
Described oligos for the following mutations were ordered (residue number and encoded amino acid): 25A, 25N, 25S, 25T, 25V, 26A, 26F, 26S, 26T, 26V, 28E, 28H, 28R, 28T, 28Y, 30A,
Structure Determination
Purified formolase enzymes were exchanged into 25 mM Tris-HCl pH 7.5 and 150 mM NaCl, concentrated to approximately 10 mg/mL, flash frozen in 50 µL aliquots and stored at -80° C. Initial crystallization conditions were obtained by screening against commercially available sparse matrices using a 'Mosquito' crystallization robot (TTP Inc.) that dispenses 50 nL sitting drops. Potential crystallization hits were then expanded/improved with using the hanging-drop vapor diffusion geometry, with 1 µL protein drops mixed with 1 µL drops of the corresponding reservoir solutions, using NEXTAL crystallization trays (Qiagen, Inc). All crystallization trials were performed at 18° C.
The one and only diffracting Des1 crystal was grown in the presence of 15% PEG3350 in 100 mM succinic Acid, pH 7.0. FLS crystals were grown repeatedly in the presence of 14 to 16% PEG3000 (w/v) in 100 mM Tris-HCl pH 7.0 plus 150 mM Ca(OAc)2. All crystals were transferred to an artificial mother liquor corresponding to the final crystallization reservoir solution augmented with 25% (v/v) ethylene glycol, then suspended in nylon loops and flash frozen by submersion in liquid nitrogen prior to data collection.
All data were collected at 100 K, and processed with the software package HKL2000. The Des1 dataset was collected on beamline 5.0.1 at the Advanced Light Source (ALS) synchrotron facilitate at Lawrence Berkeley National Laboratories (LNBL). Multiple datasets of FLS were collected either in-house on a copper rotating anode x-ray generator equipped with a Rigaku Four ++ image plate detector, or at beamline 5.0.1 at the ALS; several were used at different stages of refinement and model building. All data was processed using the HKL2000 program suite (13) . Only the final data and refinement statistics, corresponding to the dataset that gave the highest resolution and final refined model, are reported in Supplementary Table 1. All stages of both structure determinations and refinements were performed using programs in the CCP4 program suite with the 'ccp4i' interface (14) . A single polypeptide coordinates was extracted from the RCSB entry 2AGO and used as template for molecular replacement using PHASER (15) . Models were refined using Refmac5 after each cycle of model rebuilding using the molecular graphic program COOT (16, 17) .
Structure data deposition
X-ray crystallographic coordinate data has been deposited in the RCSB under PDB IDs 4QPZ (Des1) and 4QQ8 (FLS).
Protein Purification
Constructs, pET29b+ versions, were transformed into chemical competent E. coli strain BL21 (DE3). A single colony was picked and cultured overnight in 3 mL terrific broth (TB) medium at 37˚C. In the morning, this culture was decanted into 0.5 L of TB medium, incubated and shaken at 37°C until an optical density (OD600) of 0.6-0.8 was achieved. Then, expression of the gene of interest was induced with 1 mM IPTG. After 30 hours, the cells were pelleted by centrifugation, resuspended in PBS, pH 7.5, 1 mM β-mercaptoethanol (βME), 1 mM MgSO4, 0.2 mM thiamine pyrophosphate (TPP) and 10 mM imidazole and lysed by sonication in the presence of 0.1 mg/mL chicken egg lysozyme. Lysates were cleared of cell debris by centrifugation and purified using Co-NTA IMAC resin. 30mL of cleared lysate was applied to 1mL of Talon resin in a gravity fed column. The resin was washed three times with 20 mL PBS pH 7.5, 1 mM βME, 1 mM MgSO4, 0.2 mM TPP and 10 mM imidazole. Eluted was done with 15 mL PBS, pH 7.5, 1 mM βME, 1 mM MgSO4, 0.2 mM TPP and 200 mM imidazole. Eluate was concentrated to approximately 1mL prior to dialysis against PBS pH 7.5, 0.5 mM βME, 1 mM MgSO4 and 0.2 mM TPP.
Enzyme Assays
Unless otherwise noted, assay reagents used were sourced from Sigma.
